Study supports UK’s decision to extend second COVID-19 vaccination to 12 weeks

By | July 30, 2021
Findings from a study conducted in the UK support the country’s decision to extend the dosing interval of coronavirus disease 2019 (COVID-19) vaccination from 3 weeks to 12 weeks in order to prioritize the first dose for those at high risk of severe disease and death.